Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Medicine|July 31, 2021
Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern CaliforniaNicholas J Salgia, Alexander Chehrazi-Raffle, JoAnn Hsu, et al.
European Urology Focus|April 5, 2024
Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor-based CombinationsGeorges Gebrael, Luis Meza, Xiaochen Li, et al.
Frontiers in Immunology|August 28, 2023
Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profilesAmeish Govindarajan, Nicholas J Salgia, Haiqing Li, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
Research Square|August 23, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaborationTanya Dorff, Zeynep Zengin, Nicholas Henderson, et al.
Frontiers in Oncology|October 23, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinomaSalvador Jaime-Casas, Regina Barragan-Carrillo, Miguel Zugman, et al.
Journal for Immunotherapy of Cancer|May 5, 2026
Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinomaAmeish Govindarajan, Nathaniel Hansen, Benjamin D Mercier, et al.
JCO Precision Oncology|April 10, 2025
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung CarcinomaSalvador Jaime-Casas, Neal S Chawla, Nicholas J Salgia, et al.
The Oncologist|March 27, 2023
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort AnalysisLuis Meza, Zeynep Zengin, Sabrina Salgia, et al.
Nature Medicine|March 1, 2022
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialNazli Dizman, Luis Meza, Paulo Bergerot, et al.
Pageof 3